HomeNewsBusinessMarketsTough times do not last forever, crisis-driven weakness an opportunity: Gaurav Dua

Tough times do not last forever, crisis-driven weakness an opportunity: Gaurav Dua

Our Top Value Picks with 12-18 month investment horizon are: Bharti Airtel, ICICI Bank, Tata Consumer, Bajaj Finserv, and Hero MotoCorp.

July 01, 2020 / 12:17 IST
Story continues below Advertisement

This is not the first time the equity markets have witnessed sharp correction and it would not be the last time. Crisis-driven weakness and volatility is an opportunity to invest in the equity market for handsome returns over the next few years. This time is no different, Gaurav Dua, SVP, Head - Capital Market Strategy & Investments, Sharekhan by BNP Paribas, said in an interview with Moneycontrol’s Kshitij Anand.

Edited excerpt: Q) IMF global outlook is slightly worrying but is not something that is not known to markets. We saw some knee-jerk reaction in equities across the globe, and India was no exception amid rising cases of COVID-19. Do you think these factors would cap the upside for Indian markets?
A) Corona pandemic has serious consequences for Indian as well as the global economy. IMF and other reported institutions estimate contraction of 3-5 percent in the global economy in the year 2020.

However, the policy response by central bankers and government across the world has been pretty aggressive. A fiscal and monetary stimulus to tune of US $19-20 trillion has been announced globally.

Story continues below Advertisement

In the US alone, the US Federal Reserve balance sheet has expanded by $6.2 trillion in 2020 (almost 30% of US economy). The gush of money and signs of flattening of the corona curve in many nations has supported equity markets.

With the recovery of over 30 percent in Indian equities, the valuations are not cheap anymore and further upside would be dependent on the pace of recovery as the lockdown unwinds and businesses stabilise.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show